drugset / Trial / NCT01548417

Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists

NCT01548417

RandomizedParallel-groupTriple-blind

Summary

The primary hypotheses under test are that alcohol dependent subjects treated with mifepristone will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.

Timeline

Start
2012-03
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mifepristone Small molecule 600 mg Oral

Indications